Solid tumors
Sodium Thiosulfate FDA apporval to reduce the risk of Ototoxicity associated with Cisplatin in Pediatric patients
On September 20, 2022, the #FDA approved #sodium_thiosulfate to reduce the risk of #ototoxicity associated with #cisplatin in pediatric patients...
Dabrafenib + Trametinib FDA approval for treatment of adult and pediatric patients (aged 6 and older) with unresectable or metastatic solid tumors with BRAF V600E mutation
On June 22, 2022, the #FDA granted an accelerated approval to #dabrafenib in combination with #trametinib for treatment of adult...
.png)